Polycystic ovary syndrome
Clicks: 140
ID: 270779
2007
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.0
/100
10 views
10 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic …
| Reference Key |
rj2007lancetpolycystic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Norman RJ;Dewailly D;Legro RS;Hickey TE;; |
| Journal | Lancet (London, England) |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
infertility
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
risk factors
insulin resistance
female / physiopathology
polycystic ovary syndrome* / therapy
pmid:17720020
doi:10.1016/s0140-6736(07)61345-2
robert j norman
didier dewailly
theresa e hickey
anovulation / physiopathology
anovulation / therapy
gonadotropins / metabolism
hyperandrogenism / physiopathology
hyperandrogenism / therapy
female / therapy
polycystic ovary syndrome* / diagnosis
polycystic ovary syndrome* / physiopathology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.